90 related articles for article (PubMed ID: 2690109)
1. Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease.
Mastaglia FL; Masters CL; Beyreuther K; Kakulas BA
Prog Clin Biol Res; 1989; 317():475-84. PubMed ID: 2690109
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease.
Mastaglia FL; Johnsen RD; Byrnes ML; Kakulas BA
Mov Disord; 2003 Jan; 18(1):81-6. PubMed ID: 12518303
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta-peptide and the dementia of Parkinson's disease.
Jendroska K; Lees AJ; Poewe W; Daniel SE
Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
[TBL] [Abstract][Full Text] [Related]
4. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
5. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
[TBL] [Abstract][Full Text] [Related]
8. The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease.
Brilliant MJ; Elble RJ; Ghobrial M; Struble RG
Neuropathol Appl Neurobiol; 1997 Aug; 23(4):322-5. PubMed ID: 9292871
[TBL] [Abstract][Full Text] [Related]
9. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
10. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
[TBL] [Abstract][Full Text] [Related]
11. Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia.
Zekry D; Duyckaerts C; Belmin J; Geoffre C; Moulias R; Hauw JJ
Acta Neuropathol; 2003 Oct; 106(4):367-73. PubMed ID: 12898153
[TBL] [Abstract][Full Text] [Related]
12. Elevated cortical zinc in Alzheimer disease.
Religa D; Strozyk D; Cherny RA; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush AI
Neurology; 2006 Jul; 67(1):69-75. PubMed ID: 16832080
[TBL] [Abstract][Full Text] [Related]
13. [Alzheimer's disease: the beta amyloid protein A4 is also present in the cortical white matter].
Behrouz N; Defossez A; Delacourte A; Mazzuca M
C R Acad Sci III; 1990; 310(11):539-44. PubMed ID: 2114194
[TBL] [Abstract][Full Text] [Related]
14. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
[TBL] [Abstract][Full Text] [Related]
15. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
[TBL] [Abstract][Full Text] [Related]
16. [Sporadic cerebral amyloid angiopathy presenting with dementia and prominent capillary beta-amyloid deposition: a case report].
Yamashita M; Yamamoto T; Yamada M; Okino S; Fujita T
Rinsho Shinkeigaku; 2002 Jun; 42(6):530-5. PubMed ID: 12607981
[TBL] [Abstract][Full Text] [Related]
17. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease.
Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
Acta Neuropathol; 2003 Jul; 106(1):83-8. PubMed ID: 12687392
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
Yilmazer-Hanke DM
Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
[TBL] [Abstract][Full Text] [Related]
19. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
[TBL] [Abstract][Full Text] [Related]
20. [Similarities between cerebral amyloid plaques in aged lemurian and in human with Alzheimer's disease].
Bons N; Mestre N
C R Seances Soc Biol Fil; 1993; 187(4):516-25. PubMed ID: 8019922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
